Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Semi-parametric and non-parametric methods for clinical trials with incomplete data.

Peter C O'Brien1, David Zhang, Kent R Bailey

  • 1Division of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. obrien@mayo.edu

Statistics in Medicine
|November 18, 2004
PubMed
Summary

New methods for clinical trial data analysis, Cumulative Change and Last Rank Carry Forward (LRCF), outperform Last Observation Carried Forward (LOCF) and Completers analyses, offering more accurate and powerful results for incomplete data. These approaches improve statistical rigor in clinical research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.

JCI insight·2026
Same author

Signal in the Noise: Polygenic Scores and the Problem of Defining Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Progressive Fusion of Multi-Scale Mamba Context and Local Detail Priors for Infrared Small Target Detection.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Publisher Correction: Whole genome sequence analysis of pulmonary function and COPD in 44,287 multi-ancestry participants.

Genome biology·2026
Same author

Optical Coherence Tomography Biomarkers Differentiate Epiretinal Membranes Secondary to Retinal Detachment from Idiopathic Epiretinal Membranes.

Journal of vitreoretinal diseases·2026

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Statistical Analysis

Background:

  • Clinical trials frequently encounter incomplete data, necessitating robust analytical methods.
  • Last Observation Carried Forward (LOCF) and Completers analyses are common but can yield biased results.
  • Existing methods may not adequately address unequal censoring in treatment arms.

Purpose of the Study:

  • To propose and evaluate alternative methods for analyzing clinical trial data with incomplete endpoint measurements.
  • To compare the performance of proposed methods against traditional LOCF and Completers analyses.
  • To identify statistically sound and efficient approaches for handling missing data in longitudinal studies.

Main Methods:

  • Introduced two novel methods: Cumulative Change (a semi-parametric approach) and Last Rank Carry Forward (LRCF, a non-parametric analogue of LOCF).

Related Experiment Videos

  • Conducted simulations reflecting chronic disease scenarios with unequal censoring.
  • Compared Cumulative Change, LRCF, Completers, and LOCF methods regarding bias, type I error rates, power, and estimation efficiency.

    • Main Results:

    • LOCF demonstrated marked bias and inflated type I error rates under unequal censoring.
    • Completers, Cumulative Change, and LRCF methods did not exhibit these issues.
    • Cumulative Change and LRCF were more powerful than Completers and provided more efficient estimates.

    Conclusions:

    • Cumulative Change and LRCF methods are statistically superior to LOCF and Completers analyses for incomplete clinical trial data.
    • Mixed Model Repeated Measures (MMRM) is also a viable alternative, with assumptions less restrictive than LOCF and Completers.
    • These findings advocate for the adoption of Cumulative Change and LRCF in clinical trial data analysis to improve reliability.